Related Articles
Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX‑2/PGE2 pathway
Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway
Leptin upregulates smooth muscle cell expression of MMP‑9 to promote plaque destabilization by activating AP‑1 via the leptin receptor/MAPK/ERK signaling pathways
Aspirin suppresses TNF‑α‑induced MMP‑9 expression via NF‑κB and MAPK signaling pathways in RAW264.7 cells
Specific matrix metalloproteinases and calcification factors are associated with the vulnerability of human carotid plaque